rs743554
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000154.2(GALK1):c.1108-40C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.149 in 1,609,576 control chromosomes in the GnomAD database, including 19,145 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.16 ( 2246 hom., cov: 33)
Exomes 𝑓: 0.15 ( 16899 hom. )
Consequence
GALK1
NM_000154.2 intron
NM_000154.2 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.441
Publications
29 publications found
Genes affected
GALK1 (HGNC:4118): (galactokinase 1) Galactokinase is a major enzyme for the metabolism of galactose and its deficiency causes congenital cataracts during infancy and presenile cataracts in the adult population. [provided by RefSeq, Jul 2008]
GALK1 Gene-Disease associations (from GenCC):
- galactokinase deficiencyInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Myriad Women’s Health, Labcorp Genetics (formerly Invitae), G2P, Orphanet, ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.77).
BP6
Variant 17-75758167-G-A is Benign according to our data. Variant chr17-75758167-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 1180482.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.219 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.164 AC: 24961AN: 152070Hom.: 2241 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
24961
AN:
152070
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.144 AC: 33923AN: 236046 AF XY: 0.148 show subpopulations
GnomAD2 exomes
AF:
AC:
33923
AN:
236046
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.148 AC: 215599AN: 1457388Hom.: 16899 Cov.: 35 AF XY: 0.149 AC XY: 108023AN XY: 724906 show subpopulations
GnomAD4 exome
AF:
AC:
215599
AN:
1457388
Hom.:
Cov.:
35
AF XY:
AC XY:
108023
AN XY:
724906
show subpopulations
African (AFR)
AF:
AC:
7736
AN:
33458
American (AMR)
AF:
AC:
4444
AN:
44396
Ashkenazi Jewish (ASJ)
AF:
AC:
4378
AN:
26062
East Asian (EAS)
AF:
AC:
401
AN:
39630
South Asian (SAS)
AF:
AC:
15007
AN:
86054
European-Finnish (FIN)
AF:
AC:
7503
AN:
51030
Middle Eastern (MID)
AF:
AC:
1036
AN:
5744
European-Non Finnish (NFE)
AF:
AC:
166262
AN:
1110902
Other (OTH)
AF:
AC:
8832
AN:
60112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
12523
25047
37570
50094
62617
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
5888
11776
17664
23552
29440
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.164 AC: 24982AN: 152188Hom.: 2246 Cov.: 33 AF XY: 0.160 AC XY: 11906AN XY: 74396 show subpopulations
GnomAD4 genome
AF:
AC:
24982
AN:
152188
Hom.:
Cov.:
33
AF XY:
AC XY:
11906
AN XY:
74396
show subpopulations
African (AFR)
AF:
AC:
9246
AN:
41514
American (AMR)
AF:
AC:
1859
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
AC:
540
AN:
3470
East Asian (EAS)
AF:
AC:
77
AN:
5174
South Asian (SAS)
AF:
AC:
750
AN:
4832
European-Finnish (FIN)
AF:
AC:
1581
AN:
10612
Middle Eastern (MID)
AF:
AC:
58
AN:
294
European-Non Finnish (NFE)
AF:
AC:
10306
AN:
67962
Other (OTH)
AF:
AC:
316
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1057
2114
3172
4229
5286
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
266
532
798
1064
1330
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
362
AN:
3478
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jun 29, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Deficiency of galactokinase Benign:1
Jul 08, 2021
Genome-Nilou Lab
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.